Edwina Burke
Overview
Explore the profile of Edwina Burke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Hammouri T, Almeida-Magana R, Lawrence R, Duffy T, White L, Burke E, et al.
BMC Cancer
. 2023 Jun;
23(1):581.
PMID: 37353740
Background: Treatment decisions in prostate cancer (PCa) rely on disease stratification between localised and metastatic stages, but current imaging staging technologies are not sensitive to micro-metastatic disease. Circulating tumour cells...
2.
Davies C, Guo T, Burke E, Stankiewicz E, Xu L, Mao X, et al.
Front Oncol
. 2023 Feb;
12:1060864.
PMID: 36727071
Background: Docetaxel improves overall survival (OS) in castration-resistant prostate cancer (PCa) (CRPC) and metastatic hormone-sensitive PCa (mHSPC). However, not all patients respond due to inherent and/or acquired resistance. There remains...
3.
Xue X, Dong L, Burke E, Xue L, Lu Y
Am J Cancer Res
. 2022 May;
12(4):1866-1883.
PMID: 35530277
suppresses tumorigenesis through multiple cellular functions/mechanisms, including genomic stability surveillance. Recently, it has also be reported for its role in cancer immune response modulation. Deficiency in DNA repair pathways lead...
4.
Guo T, Wang Y, Jia J, Mao X, Stankiewicz E, Scandura G, et al.
Front Cell Dev Biol
. 2021 Jan;
8:602493.
PMID: 33490068
Castration-resistant prostate cancer (CRPC) is the major cause of death from prostate cancer. Biomarkers to improve early detection and prediction of CRPC especially using non-invasive liquid biopsies could improve outcomes....
5.
Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, et al.
J Urol
. 2019 Oct;
203(1):81-82.
PMID: 31580196
No abstract available.
6.
Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, et al.
J Urol
. 2019 Aug;
203(1):73-82.
PMID: 31389764
Purpose: Prostate specific antigen testing results in unnecessary biopsy and over diagnosis with consequent overtreatment. Tissue biopsy is an invasive procedure associated with significant morbidity. More accurate noninvasive or minimally...